Kaiser Permanente autism researcher answers 5 questions about what motivated her to move into this research field and the challenges in better understanding these disorders.
Women with gestational diabetes who received a tailored letter with personalized weight-gain recommendations were significantly more likely to meet national weight-gain guidelines, according to a Kaiser Permanente study published in Diabetes Care.
A study of diabetes patients at Kaiser Permanente suggests that severe episodes of hypoglycemia occur far more often than is captured in electronic medical records, pointing to a nationwide need for improved tracking of these events.
In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Northern California — maternal overweight and hyperglycemia were linked to the earlier onset of puberty in girls 6 to 11 years old.
New Kaiser Permanente study shows a better identification of low muscle and high fat might lead to better outcomes A new study by Kaiser Permanente researchers is taking on the question of how muscle, and fat, affects the overall survival…
Death rates from heart disease and stroke in adults under age 65 are lower and dropping faster for Kaiser Permanente members in Northern California than in the rest of the United States, according to new research published today in the American Journal of Medicine.
Children with autism and their younger siblings are significantly less likely to be fully vaccinated than the general population, according to new research published in JAMA Pediatrics.
Over a 10-year period, control of three key cardiovascular risk factors improved faster for Kaiser Permanente diabetes patients in Northern California than in the rest of the United States, according to research published in the American Journal of Medicine.
The second Cardiovascular Research Symposium drew approximately 80 people including researchers, sub-specialty physicians, quality and operational staff, and others from across Kaiser Permanente’s Northern California region. It was convened at the Division of Research (DOR) in Oakland by Alan S. Go, MD, DOR’s associate director of Cardiovascular and Metabolic Conditions Research.
A new study shows that a treatment regimen of 8 weeks for hepatitis C may be just as effective as 12 weeks in black patients. The study also showed that more people overall can take advantage of the shorter treatment durations, which has important implications for access given the medication’s high cost.